Details der Publikation - A virus-free vector for the transfection of somatic cells to obtain IPSC

A virus-free vector for the transfection of somatic cells to obtain IPSC

Abstract Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) is a promising tool for regenerative medicine. The fibroblast cells are the most commonly used cell type for this purpose thanks to their easy accessibility. In this study, we used the fibroblast cell line to introduce the main transcription factors (Oct4, Klf4, Sox2) for reprogramming. Controversy to literature, we used a virus-free method for introduction OKS. We developed an octadecylamine-based cationic lipid nanoparticle as a nonviral carrier. The cationic nanoparticle was prepared via the emulsion-solvent evaporation method. We used the formulation OLN32 with 29.7 ± 3.16 mV zeta potential and 118.3 ± 3.05 nm size for introducing OKS. The fibroblast L929 cell line was transfected with OLN-OKS conjugates, and the transfection efficiency was followed by observing GFP expression. The transfection efficiency was found at 72%. The expression of OKS was detected by RT-qPCR and the transfection factors were determined to be amplified after the 11th cycle..

Medienart:	E-Artikel

Erscheinungsjahr:	2019
Erschienen:	2019

Enthalten in:	Zur Gesamtaufnahme - volume:21
Enthalten in:	Journal of nanoparticle research - 21(2019), 11 vom: 15. Nov.

Sprache:	Englisch

Beteiligte Personen:	Varli, Hanife Sevgi [VerfasserIn] Alkan, Funda [VerfasserIn] Demirbilek, Murat [VerfasserIn] Türkoğlu, Nelisa [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

BKL:	51.45$jWerkstoffe mit besonderen Eigenschaften
Themen:	Fibroblast IPSC Nanoparticle Non-viral Octadecylamine Reprogramming

Anmerkungen:	© Springer Nature B.V. 2019

doi:	10.1007/s11051-019-4668-1

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2081622483

Internformat


LEADER	01000caa a22002652 4500
001	OLC2081622483
003	DE-627
005	20230503200205.0
007	cr uuu---uuuuu
008	230227s2019 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s11051-019-4668-1 \|2 doi
035			\|a (DE-627)OLC2081622483
035			\|a (DE-He213)s11051-019-4668-1-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 570 \|q VZ
084			\|a 51.45$jWerkstoffe mit besonderen Eigenschaften \|2 bkl
100	1		\|a Varli, Hanife Sevgi \|e verfasserin \|4 aut
245	1	0	\|a A virus-free vector for the transfection of somatic cells to obtain IPSC
264		1	\|c 2019
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Springer Nature B.V. 2019
520			\|a Abstract Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) is a promising tool for regenerative medicine. The fibroblast cells are the most commonly used cell type for this purpose thanks to their easy accessibility. In this study, we used the fibroblast cell line to introduce the main transcription factors (Oct4, Klf4, Sox2) for reprogramming. Controversy to literature, we used a virus-free method for introduction OKS. We developed an octadecylamine-based cationic lipid nanoparticle as a nonviral carrier. The cationic nanoparticle was prepared via the emulsion-solvent evaporation method. We used the formulation OLN32 with 29.7 ± 3.16 mV zeta potential and 118.3 ± 3.05 nm size for introducing OKS. The fibroblast L929 cell line was transfected with OLN-OKS conjugates, and the transfection efficiency was followed by observing GFP expression. The transfection efficiency was found at 72%. The expression of OKS was detected by RT-qPCR and the transfection factors were determined to be amplified after the 11th cycle.
650		4	\|a IPSC
650		4	\|a Reprogramming
650		4	\|a Non-viral
650		4	\|a Nanoparticle
650		4	\|a Octadecylamine
650		4	\|a Fibroblast
700	1		\|a Alkan, Funda \|4 aut
700	1		\|a Demirbilek, Murat \|4 aut
700	1		\|a Türkoğlu, Nelisa \|0 (orcid)0000-0003-3176-0902 \|4 aut
773	0	8	\|i Enthalten in \|t Journal of nanoparticle research \|d Springer Netherlands, 1999 \|g 21(2019), 11 vom: 15. Nov. \|h Online-Ressource \|w (DE-627)320575667 \|w (DE-600)2017013-0 \|w (DE-576)09113675X \|x 1572-896X \|7 nnns
773	1	8	\|g volume:21 \|g year:2019 \|g number:11 \|g day:15 \|g month:11
856	4	0	\|u https://dx.doi.org/10.1007/s11051-019-4668-1 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_187
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2070
912			\|a GBV_ILN_2086
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2116
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2119
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2136
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2433
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 51.45$jWerkstoffe mit besonderen Eigenschaften \|q VZ \|0 106418572 \|0 (DE-625)106418572
951			\|a AR
952			\|d 21 \|j 2019 \|e 11 \|b 15 \|c 11

A virus-free vector for the transfection of somatic cells to obtain IPSC

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände